Both cases, which centre on generic products and allegations of unfair competition, were resolved by decisions of the Federal Antimonopoly Service (FAS). The axitinib case is particularly noteworthy as a landmark precedent: the decision was upheld by the Russian Supreme Court, which ruled in favor of the FAS and the originator company.

Read the details of these cases in Kirill’s post here

As Chinese companies accelerate the pace of “going global”, intellectual property protection will support them in their presence in the international market. The Eurasian Patent Organization, covering 8 member states, is an important choice for Chinese companies to secure their intellectual property rights in the Eurasian region.

In the interview, Mr. Ivliev highlighted the unique advantages of the Eurasian patent system, the opportunities for Chinese companies and the future direction of regional IP cooperation.

The full text of the interview is available here

Within the event, Grigory Ivliev, the President of the Eurasian Patent Organization, had a meeting with Shen Changyu, the Commissioner of the China National Intellectual Property Administration (CNIPA).

The parties reached the following agreements during the meeting:

– to continue the working dialogue with the CNIPA’s experts and IT specialists online and offline;
– to establish cooperation between the Assembly of Eurasian Patent Attorneys and the All-China Patent Agents Association;
– to organize promo events in China in 2026 to develop the interest in the Eurasian patent system;
– to provide mutual support in extension of powers as International Authorities under the PCT.

More information about the conference CIPAC 2025 is available through the link

In cooperation with experts from the leading IP firms worldwide, Kluwer Patent Blog provides updates and developments in patent law, featuring in-depth analysis and insights from leading IP professionals.

You can read the post on Kluwer Patent Blog via the link.

You can read the post on Kluwer Patent Blog via the link.

Before the new law, the expenses for preliminary administrative disputes were not subject to reimbursement. The winning party could reimburse only those expenses incurred during consideration of disputes at court, including pre-trial costs. However, in a number of disputes, the interested party was required to begin proceedings with an administrative hearing in the Chamber of Patent Disputes and only then go to court.

Now the following expenses incurred during administrative proceedings can be reimbursed:
• patent and other fees;
• fees to be paid to the experts, specialists, and translators;
• fees (within reasonable limits) to be paid to patent and trademark attorneys, attorneys-at-law, other representatives;
• other expenses associated with the consideration of the dispute.

In cases where the claims are partially satisfied, the expenses are to be reimbursed proportionally to the claims satisfied.

Please feel free to contact us at office@ars-patent.com for more details regarding this issue.

The term for submission of claims is established. In accordance with the new Rule 21¹(6¹) of the Patent Regulations, the term for submission of claims when such a document is missing among the application materials (including divisional applications) received by the EAPO, is two months from the date of receipt of a Eurasian application by the EAPO. If the claims are not submitted within the above mentioned term, the Eurasian application shall be considered withdrawn. The extension of this term is not provided by the Patent Regulations; however, if the applicant misses this term, he may apply for the procedure of continuation of the prosecution provided by Rule 37(3) of the Patent Regulations.

The procedure of continuation of the prosecution has also become available in respect of Eurasian divisional applications in cases when the applicant misses a two-month term for submitting the requested claims, which comply with the requirements according to Rule 49(6) of the Patent Regulations.

The term for filing oppositions has been increased. Opposition procedures against the grant of Eurasian patents for inventions and industrial designs may now be initiated within three years from the publication date of grant of a Eurasian patent for invention or industrial design.

Industrial designs. Amendments to the provisions on the examination of Eurasian industrial design applications have been introduced. The option of mediation of a dispute in case of identity or confusing similarity of an industrial design with trademarks with an earlier priority has become available.

Please feel free to email us at office@ars-patent.com to get professional IP assistance in the Eurasian region.

Read Kirill’s study of the court case SIP-570/2022 and its conclusions via the link.

The article discusses recent legal developments in Russia concerning the patenting of new derivatives of known substances as another attempt to find a balance of the interests of originator companies, generic drug makers and society.

Read the full article via the link.

Kluwer Patent Blog is an online publishing service of Kluwer Law International. In cooperation with experts from the leading IP firms worldwide, it provides information and news on the most important and recent news in patent law.

Read the post on Kluwer Patent Blog via the link.